TY  - JOUR 
AU  - Rivera-Caravaca, José Miguel
AU  - Badimón, Lina
AU  - Ferreira-González, Ignacio
AU  - Gómez-Doblas, Juan José
AU  - Roca-Luque, Ivo
AU  - Lekuona, Iñaki
AU  - Jiménez Candil, Francisco Javier
AU  - Rodríguez-Padial, Luis
AU  - González-Juanatey, Carlos
AU  - Calvo-Jambrina, Román
AU  - Fácila, Lorenzo
AU  - Ruiz-Ortiz, Martín
AU  - Anguita, Manuel
AU  - Marín, Francisco
PY  - 2022
SN  - 1099-5129
UR  - http://hdl.handle.net/10366/161308
AB  - [EN]Vitamin K antagonists (VKAs) are effective drugs reducing the risk for stroke in atrial fibrillation (AF), but the benefits derived from such therapy depend on the international normalized ratio (INR) maintenance in a narrow therapeutic range....
LA  - eng
PB  - Oxford Academic
KW  - Atrial fibrillation
KW  - Stroke
KW  - Vitamin K antagonists
KW  - Time in therapeutic range
KW  - Quality of anticoagulation
KW  - Registry
KW  - Vitamin K
KW  - Aged
KW  - Prospective Studies
KW  - Atrial Fibrillation
KW  - Humans
KW  - Anticoagulants
KW  - International Normalized Ratio
KW  - Registries
KW  - Stroke
KW  - Middle Aged
TI  - Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry
DO  - 10.1093/europace/euab131
T2  - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
VL  - 24
M2  - 4
ER  -